Ionis Pharmaceuticals Inc (NASDAQ:IONS)

55.26
Delayed Data
As of 4:00pm ET
 -0.53 / -0.95%
Today’s Change
44.60
Today|||52-Week Range
86.58
+2.22%
Year-to-Date

Five Year Financial Summary

Total Revenue

Cash & Short Term Investments

Cash From Operations

All Currency in US Dollars4 Year
Trend

2015

2016

2017

2018
Revenue and IncomeNet Revenues283.7M346.6M507.7M599.7M
 
 
 
 
 
Cost of Goods Sold------1.8M
 
 
Depreciation And Amortization10.2M9.0M8.3M12.5M
 
 
 
 
 
 
Operating ExpensesGross Income------585.3M
 
 
General Expenses349.2M381.6M474.4M645.9M
 
 
 
 
 
Research And Development319.4M341.8M374.0M413.4M
 
 
 
 
 
Total Operating Expenses359.5M390.6M482.7M660.2M
 
 
 
 
 
 
Non-Operating ExpensesOperating Income-75.8M-44.0M24.9M-60.6M
 
 
 
 
 
Extraordinary Charge0.00-6.3M-8.1M-800.0K
 
 
 
 
Interest Expense On Debt36.7M38.8M44.8M44.8M
 
 
 
 
 
Other Expenses20.3M56.0K-3.2M-182.0K
 
 
 
 
 
 
Income Taxes, Minority Interest and Extra ItemsPre-Tax Income-87.9M-83.6M-23.3M-76.2M
 
 
 
 
 
Income Taxes-372.0K-2.9M-6.0M-291.1M
 
 
 
 
 
Minority Interest0.000.00-11.3M-58.8M
 
 
 
Net Income-88.3M-86.6M9.7M276.9M
 
 
 
 
 
 
Shares To Calculate EPSShares To Calculate EPS119.7M120.9M124.0M132.3M
 
 
 
 
 
Shares To Calculate EPS Diluted119.7M120.9M126.1M134.1M
 
 
 
 
 
 
Earnings Per ShareEPS-$0.74-$0.72$0.08$2.07
 
 
 
 
 
EPS Diluted-$0.74-$0.72$0.08$2.07